Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6808502 | 1.00 | USP2 (0.58) | USP2LMNAALDH1A1MEN1KMT2A | |
| SCHEMBL1881943 | 0.97 | USP2 (0.60) | USP2LMNAALDH1A1MEN1KMT2A | |
| Water SCHEMBL28291844 | 0.94 | USP2 (0.58) | USP2LMNAALDH1A1MEN1KMT2A | |
| SCHEMBL5713071 | 0.92 | MEN1 (0.55) | USP2LMNAALDH1A1MEN1KMT2A | |
| SCHEMBL12050435 | 0.92 | MEN1 (0.55) | USP2LMNAALDH1A1MEN1KMT2A | |
| SCHEMBL867745 | 0.92 | MEN1 (0.55) | USP2LMNAALDH1A1MEN1KMT2A | |
| SCHEMBL27620890 | 0.92 | MEN1 (0.55) | USP2LMNAALDH1A1MEN1KMT2A | |
| SCHEMBL11352485 | 0.92 | MEN1 (0.55) | USP2LMNAALDH1A1MEN1KMT2A | |
| SCHEMBL541678 | 0.92 | MEN1 (0.55) | USP2LMNAALDH1A1MEN1KMT2A | |
| SCHEMBL27953890 | 0.90 | USP2 (0.67) | USP2LMNAALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11231632-B2 | Low-volatile electro-optic electrolyte solvents containing cylic organic carbonates | GENTEX CORPORATION (US) | 2022-01-25 | — | — | US | disclosed |
| US-20200192173-A1 | LOW-VOLATILE ELECTRO-OPTIC ELECTROLYTE SOLVENTS CONTAINING CYLIC ORGANIC CARBONATES | GENTEX CORPORATION (US) | 2020-06-18 | — | — | US | disclosed |
| US-20090110649-A1 | ANTIPRURITIC COSMETIC AND DERMATOLOGICAL PREPARATIONS | BEIERSDORF AG (DE) | 2009-04-30 | — | — | US | disclosed |
| US-20060093633-A1 | Cosmetic and/or dermatological preparation comprising 2,3-dibenzylbutyrolactones | BEIERSDORF AG (DE) | 2006-05-04 | — | — | US | disclosed |
| US-20030147928-A1 | Water, oil in water emulsifiers, optionally coemulsifiers, oil phase(s), polidocanol and an essential oil; saturated cloth; immediate and long-lasting effect | BEIERSDORF AG | 2003-08-07 | — | — | US | disclosed |
| US-20030091605-A1 | Use of alpha-lipoic acid for producing cosmetic or dermatological preparations for regenerating stressed skin, in particular aged skin | BEIERSDORF AG | 2003-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090110649-A1 | ANTIPRURITIC COSMETIC AND DERMATOLOGICAL PREPARATIONS | POLR1C, POLD3, SMURF1 | USP2 942/4885LMNA 3022/4885ALDH1A1 4375/4885 |
| US-20030091605-A1 | Use of alpha-lipoic acid for producing cosmetic or dermatological preparations for regenerating stressed skin, in particular aged skin | CUTA, LIPA, LPO | USP2 2107/4885LMNA 793/4885ALDH1A1 257/4885 |
| US-20060093633-A1 | Cosmetic and/or dermatological preparation comprising 2,3-dibenzylbutyrolactones | DPM1, TYR, DSG1 | USP2 2534/4885LMNA 1421/4885ALDH1A1 548/4885 |
| US-20030147928-A1 | Water, oil in water emulsifiers, optionally coemulsifiers, oil phase(s), polidocanol and an essential oil; saturated cloth; immediate and long-lasting effect | POLD1, POLD3, POLI | USP2 553/4885LMNA 2339/4885ALDH1A1 3747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.